Felix Frueh

Felix Frueh is the Founder and Executive Partner at Opus Three LLC, a consulting firm specializing in the pharmaceutical and diagnostic industries with a focus on precision medicine, since 2012. Additionally, Felix Frueh serves as an Entrepreneur-in-Residence at the University of Basel and holds director roles at GENinCode_ Predictive Genetics and Bloom Science, Inc. Felix Frueh is also the Director and Secretary of CredibleMeds powered by AZCERT.org. As an advisor at TriAxia Health, Inc. and a co-founder and CEO of PAGE Therapeutics AG, Felix Frueh is involved in developing novel compounds to prevent metastases in solid tumor patients. Previous roles include co-founder and CSO of Selva Therapeutics, Inc., and director positions at Ariana Pharma and CAMP4 Therapeutics. Felix Frueh earned a PhD in Biochemistry and Molecular Biology from the University of Basel and completed a Research Fellowship in Molecular Pharmacology at Stanford University.